Physician profile
John Reyher
NPI 1134326002
$1,156.87
in general payments reported to CMS, 2019-2025
13 companies · $43.40 in 2025
The $43.40 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $123 · 2020: $49.14 · 2021: $264 · 2022: $57.96 · 2023: $378 · 2024: $241 · 2025: $43.40.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $662.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $662.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $488.11 | 2021-2025 | Intellis Adaptivestim, Inceptiv |
| Boston Scientific Corporation | $304.06 | 2021-2023 | Wavewriter Alpha Prime 16 |
| Nevro Corp. | $109.87 | 2020-2024 | Senza |
| Medtronic USA, INC. | $56.32 | 2019-2020 | |
| Stimwave Technologies Incorporated | $49.49 | 2019 | |
| Si-Bone, INC. | $32.75 | 2021 | |
| Globus Medical, INC. | $24.34 | 2021 | |
| Depuy Synthes Sales INC. | $18.95 | 2022 | |
| Pfizer INC. | $17.94 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $16.85 | 2019 | |
| Abbvie INC. | $13.77 | 2021 | |
| Abbott Laboratories | $12.52 | 2021 | |
| Scilex Pharmaceuticals INC. | $11.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Reyher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.